Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biomaterial development for cardiopulmonary bypass.

T Gourlay1

  • 1Cardiothoracic Surgery, National Heart and Lung Institute, Imperial College School of Medicine at Hammersmith, Hammersmith Hospital, London, UK.

Perfusion
|September 22, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Percutaneous heart valves; past, present and future.

Perfusion·2014
Same author

The aortic valve: structure, complications and implications for transcatheter aortic valve replacement.

Perfusion·2014
Same author

Cytokines in the systemic inflammatory response syndrome: a review.

HSR proceedings in intensive care & cardiovascular anesthesia·2013
Same author

The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress.

Perfusion·2010
Same author

Surgical treatment of renal cell carcinoma with right atrial thrombus: early experience and description of a simplified technique.

International journal of surgery (London, England)·2007
Same author

A recovery model of minimally invasive cardiopulmonary bypass in the rat.

Perfusion·2006

Removing plasticizers from polyvinyl chloride (PVC) tubing used in cardiopulmonary bypass (CPB) enhances biocompatibility. This reduction in inflammatory response is comparable to conventional heparin coating methods.

Area of Science:

  • Biomaterials Science
  • Immunology
  • Cardiovascular Surgery

Background:

  • Cardiopulmonary bypass (CPB) utilizes foreign materials, potentially triggering adverse inflammatory responses.
  • The exact cause of this inflammatory response during CPB is not fully understood.
  • Current strategies to mitigate CPB-induced inflammation include surface modifications and pharmacological interventions.

Purpose of the Study:

  • To investigate the role of plasticizers in polyvinyl chloride (PVC) tubing in CPB-related inflammation.
  • To evaluate the impact of plasticizer removal on the biocompatibility of CPB circuits.
  • To compare the efficacy of plasticizer removal with established anti-inflammatory strategies.

Main Methods:

  • Washing plasticizer from the surface of PVC tubing used in CPB circuits.

Related Experiment Videos

  • Assessing biocompatibility by measuring the upregulation of CD11b on neutrophils.
  • Utilizing non-plasticized PVC substitutes in CPB circuits.

    • Main Results:

    • Washing plasticizer from PVC tubing significantly enhanced biocompatibility.
    • Non-plasticized PVC substitutes also demonstrated improved biocompatibility.
    • The observed benefits of plasticizer removal were comparable to heparin surface coating.

    Conclusions:

    • Plasticizers in PVC tubing contribute to the inflammatory response during CPB.
    • Removing plasticizers or using non-plasticized alternatives is an effective strategy to improve CPB biocompatibility.
    • This approach offers an alternative or adjunct to conventional methods like heparin coating for reducing CPB-induced inflammation.